Filter
779
Text search:
in
vitro
Featured
Recommendations
94
New Publications
142
Language
Document type
No document type
323
Guidelines
220
Studies & Reports
113
Manuals
63
Strategic & Response Plan
22
Fact sheets
21
Training Material
9
Situation Updates
4
Resource Platforms
3
Brochures
1
Countries / Regions
India
30
Latin America and the Carribbean
24
Russia
23
Germany
22
South Africa
20
Brazil
16
Global
15
Africa
13
Colombia
11
Western and Central Europe
11
Argentina
9
Peru
9
Kenya
8
Bolivia
8
Ethiopia
7
Zambia
7
Paraguay
7
Eastern Europe
7
Namibia
6
Ukraine
6
Venezuela
6
Uganda
5
Tanzania
5
Rwanda
5
El Salvador
5
Burkina Faso
4
Nigeria
4
Cameroon
4
Indonesia
4
West and Central Africa
4
Middle East and North Africa
4
Sierra Leone
3
Congo, Democratic Republic of
3
Mali
3
Niger
3
Nepal
3
Benin
3
Eswatini/ Swaziland
3
Ecuador
3
Lesotho
3
Myanmar / Burma
3
East and Southern Africa
3
Eastern Europe and Central Asia
3
Congo-Brazzaville
3
France
3
Spain
3
Guinea
2
Liberia
2
Senegal
2
Côte d’Ivoire / Ivory Coast
2
Haiti
2
Philippines
2
Syria
2
Chad
2
Bangladesh
2
Malawi
2
Angola
2
Madagascar
2
Chile
2
Yemen
2
Asia
2
Tajikistan
2
Kazakhstan
2
Guinea-Bissau
1
Morocco
1
USA
1
Saudi Arabia
1
Ghana
1
Togo
1
Zimbabwe
1
Somalia
1
South Sudan
1
Iraq
1
Jordan
1
Lebanon
1
Turkey
1
Egypt
1
Gambia
1
Mauritania
1
Mozambique
1
Sudan
1
Dominican Republic
1
North Macedonia
1
Serbia
1
Cuba
1
Burundi
1
Honduras
1
Libya
1
Guatemala
1
Mexico
1
Nicaragua
1
South–East Asia Region
1
Luxembourg
1
Albania
1
Djibouti
1
Armenia
1
Mongolia
1
Southern Africa
1
Laos
1
Canada
1
Qatar
1
Uzbekistan
1
Kyrgyzstan
1
Georgia
1
North America
1
Belgium
1
Tunisia
1
Belarus
1
Israel
1
Authors & Publishers
Publication Years
Category
Countries
228
Clinical Guidelines
147
Pharmacy & Technologies
42
Women & Child Health
22
Public Health
20
Key Resources
16
Toolboxes
COVID-19
141
TB
107
HIV
85
AMR
49
NTDs
42
Pharmacy
31
Ebola
28
Rapid Response
26
Zika
16
Caregiver
14
Refugee
13
Planetary Health
12
Mental Health
11
Polio
6
NCDs
5
Conflict
3
Specific Hazards
3
Global Health Education
3
Cholera
2
Natural Hazards
2
Disability
1
Social Ethics
1
PQDx 0159-055-00
WHO PQ Public Report
February/2017, version 5.0
Tests zur Detektion einer Infektion mit SARS-CoV-2 (neuartiges Coronavirus) sowie zum Nachweis von Antikörpern gehören zu den sog. In-vitro-Diagnostika (IVD). Das erstmalige Inverkehrbringen von
...
PQDx 0053-006-00 WHO
PQ Public Report
June/2016, version 2.0
Qualitative assay for use on the cobas®6800/8800 Systems. For in vitro diagnostic use
PQDx 0183‐060‐00 WHO
PQ Public Report
October/2016, version 5.0
PQDx 0027-012-00 WHO
PQDx Public Report
May/2017, version 4.0
WHO estimates that in 2015, 257 million people were living with chronic hepatitis B virus (HBV) infection worldwide, and that 900 000 died from HBV infection, mostly through the development of cirrhosis and hepatocellular carcinoma. Worldwide, the m
...
PQDx 0144-043-00 WHO
PQDx Public Report
November/2016, version 4.0
The purpose of this TPP is to communicate the minimum and ideal characteristics desired to meet the need for discriminating low levels of risk for transmission, i.e. targeted prevalence thresholds in the surveyed areas. An
...
The global pandemic has highlighted fragility in international supply chains and the dependency of many African countries on imported personal protective equipment (PPE). Market pressures have also increased prices for imported supplies and put addi
...
PQDx 0214-064-00
WHO PQDx PR
April/2016, version 3.0
Annex to Selection and use of Ebola in vitro diagnostic assays
Chikungunya virus (CHIKV) is currently one of the most relevant arboviruses to public health. It is a member of the Togaviridae family and alphavirus genus and causes an arthritogenic disease known as chikungunya fever (CHIKF). It is characterized by a multifaceted disease, which is distinguished fr
...
PQDx 0179-012-00 WHO
PQDx Public Report
June/2017, version 4.0
This document provides brief information answering common questions regarding COVID-19 diagnostic tests and how to prioritize them to the patients most in need.
A recent study informed that ivermectin was successfully used in vitro for the treatment of SARS-CoV-2 in experimentally infected cells and two pre
...
Esta primeira versão de Medicamentos para prevenção da COVID-19: Orientação dinâmica da OMS aborda o uso de hidroxicloroquina para prevenção da COVID-19. Segue-se a publicação de uma análise sistemática e NMA que reuniu dados de seis estudos com 6.059 participantes que não tinham COVID-
...